Streetbeat News

Earnings

QBTS

D-Wave Quantum's shares dropped following a report of lower than expected Q4 revenue.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:33 am

SHIM

Shimmick (NASDAQ:SHIM) reported Q4 earnings with a loss of $(0.59) per share, significantly missing the $(0.20) estimate. Quarterly sales were $138.00M, also missing the $158.50M estimate.

Portfolio Pulse from dijoy@benzinga.com

March 28, 2024 | 11:33 am

CWCO

Consolidated Water Co. (CWCO) shares surged following the announcement of their Q4 earnings, which exceeded analysts' expectations in both EPS and sales.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:31 am

RH

RH shares surged following the announcement of their Q4 financial results and future guidance. Additionally, Telsey Advisory Group upheld a Market Perform rating for RH but increased the price target from $285 to $335.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:30 am

CASI

CASI Pharmaceuticals reported FY2023 GAAP EPS of $(2.02), missing the $(1.93) estimate, and sales of $33.88M, missing the $36.42M estimate. This represents a 32.89% increase in losses per share and a 21.41% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:29 am

EM

Smart Share Glb (EM) reported Q4 sales of $68.54M, missing the $72.02M estimate, a 20.80% decrease from $86.54M last year. Q4 EPS improved to $0 from -$0.18 YoY.

Portfolio Pulse from dijoy@benzinga.com

March 28, 2024 | 11:29 am

CALC

CalciMedica reported a significant improvement in its FY23 earnings per share (EPS), posting $(7.66) compared to $(111.16) in the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:28 am

MNPR

Monopar Therapeutics (NASDAQ:MNPR) reported a Q4 GAAP EPS loss of $(0.12), surpassing the analyst consensus estimate of $(0.15) by 20%. This represents a 45.45% improvement over the $(0.22) per share loss from the same quarter last year.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:26 am

CXM

Sprinklr's stock price increased following the announcement of their Q4 financial results, which exceeded expectations. Additionally, the company provided optimistic revenue guidance for the future.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:25 am

CANF

Can Fite Biofarma (AMEX:CANF) reported its FY GAAP EPS at $(0.01), unchanged YoY, with sales of $743.00K, down 8.27% from $810.00K YoY.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:23 am